EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease

Erica Mulcaire-Jones, Janelle Vu Pugashetti, Justin M Oldham, Dinesh Khanna

Seminars in Respiratory and Critical Care Medicine · 01.06.2024 · 45 (03) · 435-448

DOI: 10.1055/s-0044-1786155 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.06.2024. Verfasst von Erica Mulcaire-Jones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Internal Medicine, University of Michigan, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Connective Tissue Diseases, Immunosuppressive Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Connective tissue diseases (CTD) comprise a group of autoimmune diseases that can affect multiple organs in the body including the lungs. The most common form of pulmonary involvement is interstitial lung disease (ILD). CTD-associated ILD (CTD-ILD) can take one of several courses including nonprogressive, chronically progressive, or rapidly progressive. Chronically and rapidly progressive patterns are associated with increased mortality. Limited randomized controlled trial data are available for treatment of CTD-ILD, with most data coming from systemic sclerosis-related ILD. The current first-line treatment for all CTD-ILD is immunosuppression with consideration of antifibrotics, stem cell transplant, and lung transplant in progressive disease. In this article, we review data for ILD treatment options in systemic sclerosis, rheumatoid arthritis, myositis, and primary Sjögren's syndrome-related ILDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialConnective Tissue DiseasesImmunosuppressive AgentsHumansLung TransplantationDisease ProgressionStem Cell TransplantationSjogren's SyndromeScleroderma, SystemicArthritis, RheumatoidRandomized Controlled Trials as TopicMyositis

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Division of Rheumatology, Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Division of Pulmonary and Critical Care Medicine, Internal Medicine, University of Michigan, Ann Arbor, Michigan.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Mulcaire-Jones, E., Pugashetti, J. V., Oldham, J. M., & Khanna, D. (2024). Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease. Seminars in Respiratory and Critical Care Medicine, 45(03), 435-448. https://doi.org/10.1055/s-0044-1786155

Vancouver

Mulcaire-Jones E, Pugashetti JV, Oldham JM, Khanna D. Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease. Seminars in Respiratory and Critical Care Medicine. 2024;45(03):435-448. doi:10.1055/s-0044-1786155

BibTeX
@article{MulcaireJones2024,
  author = {Mulcaire-Jones, Erica and Pugashetti, Janelle Vu and Oldham, Justin M and Khanna, Dinesh},
  title = {Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease},
  journal = {Seminars in Respiratory and Critical Care Medicine},
  year = {2024},
  volume = {45},
  number = {03},
  pages = {435--448},
  doi = {10.1055/s-0044-1786155}
}
Kostenlos starten →